Vilazodone acts as a multimodal antidepressant for managing emotional states. By modulating serotonin signaling through reuptake inhibition and partial receptor activation, it assists in restoring neurochemical balance and cognitive clarity.
Vilazodone belongs to the class of serotonin-modulating agents used to influence mood regulation. It appears as the central active component in several formulations, most notably the brand-named product Viibryd. The molecule acts by enhancing serotonin activity while also providing a modest boost to neurotransmitter balance, a profile that differentiates it from many other antidepressant agents.
In Singapore, Vilazodone is available primarily as oral tablets marketed under the name Viibryd. Both generic versions and the branded product share the same therapeutic ingredient, though they may differ in packaging, tablet strength, and manufacturer markings. The tablets are designed for swallowing whole and are supplied in quantities that suit short-term or longer-term treatment plans as determined by a prescriber.
These applications arise because the drug can modulate serotonergic pathways thought to be involved in these conditions.
Vilazodone works by increasing the availability of serotonin, a chemical messenger linked to mood and anxiety regulation. It does this through a dual action: it blocks the re-uptake of serotonin, allowing more of the neurotransmitter to remain active, and it also stimulates specific serotonin receptors, which can further uplift mood. This combined effect aims to produce a smoother emotional balance over several weeks of consistent use.
These symptoms typically lessen as the body adjusts.
Any abrupt or severe symptom should prompt immediate medical attention.
For a complete list of interacting agents, refer to the specific medication’s detailed information.
Store tablets in a cool, dry place away from direct sunlight, and keep them out of reach of children. The typical treatment course can range from several weeks for an acute episode to longer periods for chronic management, depending on the prescriber’s assessment. Because strengths and dosing instructions vary between Viibryd and generic versions, always follow the guidance printed on the individual product’s label.
This article provides an educational overview of Vilazodone as an active substance and does not constitute medical advice. Individual medicines containing this component, such as Viibryd, may differ in formulation, strength, and usage directions. Responsibility for clinical decisions rests with the patient and their healthcare team. Readers are encouraged to review the labeling of their specific product and seek guidance from a healthcare professional for personalized information.